Christel Desmaretz

Christel Desmaretz is a Mycobacteriology researcher at the Institute of Tropical Medicine Antwerp (ITG) in Belgium, with active research output from 2015-2020. Her work focuses on tuberculosis drug resistance mechanisms and diagnostic methodologies, particularly concerning Mycobacterium tuberculosis.

Her research interests center on antimicrobial susceptibility testing, drug resistance mechanisms in tuberculosis, and diagnostic method validation. She specializes in bedaquiline resistance determination, pyrazinamide resistance detection, and molecular diagnostics for rifampicin resistance. Her fingerprint analysis shows strong concentration in Mycobacterium tuberculosis (100%), Agar (67%), Pharmaceutical Preparations (52%), Growth (23%), and Silent Mutation (6%) research areas.

Analysis of her publication record reveals a clear trend toward multicountry, collaborative studies on TB drug resistance diagnostics, with increasing focus on molecular methods and breakpoint validation. Her work has been referenced in policy sources and patents, demonstrating translational impact in clinical practice.

Based on available information, no formal scientific awards have been documented in the provided materials.

Dr. Desmaretz participates in international collaborative research networks focused on tuberculosis diagnostics, working with laboratories across multiple countries to standardize drug susceptibility testing methods. Her research contributes to global efforts in combating drug-resistant tuberculosis through improved diagnostic accuracy.